Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Quantum Diamond Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Quantum Diamond Technologies

Quantum Diamond Technologies

Quantum Diamond Technologies Inc., based in Somerville, US, specializes in physical, biological R&D and bio marker diagnostics.

HQ
Somerville, MA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Quantum Diamond Technologies Inc. (QDTI), founded in Somerville, US, focuses on advancing physical and biological research and development. The company's core mission is to revolutionize biomarker diagnostics through quantum-powered technologies. QDTI offers an ultrasensitive, simple, and fast biomarker diagnostics platform designed to meet the growing demand for accurate and user-friendly diagnostic tools. Their market focus includes healthcare providers and research institutions in the United States.

Notable affiliated individuals include leading scientists and researchers in the field of quantum technology. QDTI has garnered attention from prominent investors interested in cutting-edge diagnostic solutions. Key achievements include the development of a highly sensitive diagnostic instrument, which has been highlighted in recent publications for its efficacy and simplicity. Overall, QDTI is making significant strides in improving diagnostic accuracy and accessibility, impacting both clinical and research settings.

Quantum Diamond Technologies - Similar Companies

Quanterix logo

Quanterix

NanoDetection Technology logo

NanoDetection Technology

Q Bio logo

Q Bio

q.bio

GenQual logo

GenQual

genqual.com

Diamir logo

Diamir

diamirbio.com

Adamas Nanotechnologies logo

Adamas Nanotechnologies

adamasnano.com

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

SeQure Dx logo

SeQure Dx

sequre-dx.com

Nanopath logo

Nanopath

nanopathdx.com

Diomics logo

Diomics

Quantrx Biomedical logo

Quantrx Biomedical

Test Diagnostics logo

Test Diagnostics

Diagmetrics logo

Diagmetrics

diagmetrics.com

Persperion Diagnostics logo

Persperion Diagnostics

persperiontech.com

Dots Technology logo

Dots Technology

dotscorp.com

Quantum Diamond Technologies - Quick Facts

Who are Quantum Diamond Technologies' competitors?

Companies similar to Quantum Diamond Technologies include Quanterix, NanoDetection Technology, Q Bio and GenQual.

When was Quantum Diamond Technologies founded?

Quantum Diamond Technologies was founded in 2012.

Where is Quantum Diamond Technologies' headquarters located?

Quantum Diamond Technologies' headquarters is located in Somerville, MA, US.

When was Quantum Diamond Technologies' last funding round?

Quantum Diamond Technologies' most recent funding round was for $800k (USD) in January 2018.

How much has Quantum Diamond Technologies raised to-date?

As of Jan 1, 2018, Quantum Diamond Technologies has raised a total of $1M (USD).

How many employees does Quantum Diamond Technologies have?

Quantum Diamond Technologies has 30 employees as of Feb 4, 2024.

Quantum Diamond Technologies - Classification

Ownership
  • Private
Technology
  • AI
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biomarker Diagnostics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research